In-person versus telehealth outpatient palliative care visits in oncology: A multicenter study.

S Sarah Ananda Gomes (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) F Flavia Santos Dumont Sorice (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Cecilia Emerick Mendes Vaz (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) A Ana Maria do Amaral Ribeiro Alves (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) A Amanda Pifano Soares Ferreira (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) J Júlia Sá (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) R Raquel Gouveia (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) J Jaqueline Santos (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) R Renata Ferrari (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) N Natacha Silva Moz (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Christopher Negrete (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) R Rodrigo Dienstmann M Maria Helena Cruz Rangel da Silva (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) M Mariana Laloni (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Carlos Gil Moreira Ferreira (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), São Paulo, Brazil) B Bruno Lemos Ferrari (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), São Paulo, Brazil) R Rafael Duarte Paes (Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Cristiane Decat Bergerot (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil)

Abstract

12056 Background: As telehealth becomes integral to outpatient palliative care delivery in oncology, evidence comparing consultation duration and time allocation between in-person and remote visits remains limited, especially in low- and middle-income countries. We compared consultation duration and time composition between in-person and telehealth visits after adjustment for visit type and clinical complexity. Methods: This observational study evaluated outpatient oncological palliative care consultations conducted between February and May 2025 across seven practices in Brazil. Total consultation time and predefined time components were recorded. Multivariable linear regression models estimated adjusted differences in consultation duration according to care modality, controlling for visit type (first appointment, follow-up, family meeting), performance status (ECOG), quality-of-life (IPOS), and number of participants. Results: A total of 269 consultations were analyzed, including 171 in-person and 98 telehealth visits. Care modality was associated with consultation type (p < 0.001): telehealth was less frequently used for first consultations (15% vs. 35%) and more frequently used for follow-up visits (76% vs. 63%) and family meetings (9% vs. 3%). Telehealth visits involved patients with worse performance status (ECOG 3-4: 36% vs. 17%; p=0.007) and poorer quality of life (higher IPOS distribution; p=0.037). In unadjusted analyses, telehealth consultations were shorter than in-person visits, particularly for follow-up visits. After multivariable adjustment, telehealth visits remained independently and significantly shorter by a mean of 10.5 minutes (95% confidence interval [CI] -15.6 to -5.4; p<0.001). Follow-up consultations were consistently shorter than first consultations by 19.4 minutes (95% CI -24.9 to -14.0; p<0.001), regardless of care modality, while family meetings showed no difference in duration compared with first consultations (95% CI -13.8 to 8.9; p=0.70). Each additional healthcare provider was associated with a 2.9 minute increase in consultation time (95% CI 0.1 to 5.6; p=0.04). ECOG was not independently associated with total consultation duration. Conclusions: After accounting for visit type and clinical context, differences in consultation duration between telehealth and in-person are modest. Telehealth was preferentially used for follow-up care and among patients with poorer functional status and quality of life, while preserving consultation complexity when clinically indicated. These findings support telehealth as a viable modality for outpatient palliative care delivery in resource-limited settings.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
Pages 12056-12056
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (18)

S

Sarah Ananda Gomes

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

F

Flavia Santos Dumont Sorice

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Cecilia Emerick Mendes Vaz

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

A

Ana Maria do Amaral Ribeiro Alves

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

A

Amanda Pifano Soares Ferreira

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

J

Júlia Sá

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

R

Raquel Gouveia

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

J

Jaqueline Santos

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

R

Renata Ferrari

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

N

Natacha Silva Moz

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Christopher Negrete

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

R

Rodrigo Dienstmann

M

Maria Helena Cruz Rangel da Silva

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

M

Mariana Laloni

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Carlos Gil Moreira Ferreira

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), São Paulo, Brazil

B

Bruno Lemos Ferrari

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), São Paulo, Brazil

R

Rafael Duarte Paes

Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Cristiane Decat Bergerot

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil